“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.
Timothy Burns
Advertisement
Articles by Timothy Burns
Advertisement
Latest Updated Articles
Out of Several Recent Drug Approvals in NSCLC, Tabrecta Most 'Practice Changing' of All, According to ExpertPublished: July 13th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5